Evaluation of safety of insulin degludec on undergoing total colonoscopy using continuous glucose monitoring
Authors:
Open Access
- 6 September 2015
- journal article
- research article
- Published by Wiley in Journal of Diabetes Investigation
- Vol. 7 (3) , 374-380
Abstract
Aims/Introduction: There is little information regarding how to use insulin degludec (D) when diabetic patients are preparing for total colonoscopy (TCS).Materials and Methods: A total of 12 patients with type 2 diabetes treated with insulin D and scheduled to undergo TCS were enrolled in the present study. A continuous glucose monitoring device was attached to each patient for 4 days, from two evenings before TCS to the morning after the procedure. The patients fasted for 24 h, starting after 18.00 h the day before TCS. Insulin D was only discontinued the morning of the day TCS was carried out.Results: No patients experienced hypoglycemia during the daytime fasting period (08.00–18.00 h the day of TCS); the hypoglycemic index, mean glucose level, and standard deviation were 0, 141.3 ± 31.5 mg/dL and 15.6 ± 6.5 mg/dL. The mean glucose level and standard deviation during the daytime fasting period were significantly lower than during the daytime control period (08.00–18.00 h the day before TCS; P = 0.003, P = 0.001, respectively). The mean fasting glucose and fasting plasma glucose levels were significantly correlated (r = 0.78, P = 0.002), as were both the mean glucose level and standard deviation during the daytime control period, and the change in the mean glucose level (fasting period minus control period; r = −0.79, P = 0.002, and r = −0.69, P = 0.01, respectively).Conclusions: Patients can safely undergo TCS when insulin D is discontinued only once on the day of the procedure.Keywords
This publication has 13 references indexed in Scilit:
- Design of the Novel Protraction Mechanism of Insulin Degludec, an Ultra-long-Acting Basal InsulinPharmaceutical Research, 2012
- Continuous glucose monitoring with Humalog Mix 25 versus Humalog Mix 50, twice daily: A comparative pilot study -Results from the Jikei-EValuation of insulin Lispro mixture on pharmacodynamics and glycemic VariancE (J-EVOLVE) studyCardiovascular Diabetology, 2010
- Effectiveness of Continuous Glucose Monitoring in a Clinical Care EnvironmentDiabetes Care, 2009
- New and Improved Methods to Characterize Glycemic Variability Using Continuous Glucose MonitoringDiabetes Technology & Therapeutics, 2009
- Hyperglycemic Crises in Adult Patients With DiabetesDiabetes Care, 2009
- Peutz–Jeghers syndrome and screening for pancreatic cancerBritish Journal of Surgery, 2006
- Diabetes Mellitus and the Risk of CancerArchives of internal medicine (1960), 2006
- Diabetes Mellitus and Risk of Colorectal Cancer: A Meta-AnalysisJNCI: Journal of the National Cancer Institute, 2005
- Diabetes increases the risk of chronic liver disease and hepatocellular carcinomaGastroenterology, 2004
- Association between diabetes mellitus and hepatocellular carcinoma: results of a hospital- and community-based case-control study.The Kurume Medical Journal, 2003